Perspective: targeting nitric oxide in the adjuvant therapy of sepsis and meningitis.
Shenep
J L
JL
Department of Infectious Diseases, St. Jude Children's Research Hospital, University of Tennessee, Memphis 38105-2794, USA. jerry.shenep@stjude.org
Tuomanen
E
E
D000818:Animals; D000890:Anti-Infective Agents / Q000378:metabolism*; D004790:Enzyme Induction; D006801:Humans; D008264:Macrophages / Q000276:immunology; D008581:Meningitis / Q000188:drug therapy*; D018448:Models, Immunological; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000187:drug effects*; D018805:Sepsis / Q000188:drug therapy*
D000890:Anti-Infective Agents; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase